Association between interleukin-22 genetic polymorphisms and bladder cancer risk

Por Zhao, Tao, Wu, XiaoHou, Liu, JiaJi
Publicado no Clinics (Sao Paulo) (2015)

miR-93 Promotes the Growth and Invasion of Prostate Cancer by Upregulating Its Target Genes TGFBR2, ITGB8, and LATS2

Por Liu, Jia-Ji, Zhang, Xuan, Wu, Xiao-Hou
Publicado no Mol Ther Oncolytics (2018)

Upregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells

Por He, Yun-Feng, Tian, Dai-Yin, Yi, Zheng-Jin, Yin, Zhi-Kang, Luo, Chun-Li, Tang, Wei, Wu, Xiao-Hou
Publicado em 2012

Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivo

Por Du, Hong-Fei, Ou, Li-Ping, Lv, Chang-Kun, Yang, Xue, Song, Xue-Dong, Fan, Yan-Ru, Wu, Xiao-Hou, Luo, Chun-Li
Publicado no Cancer Biol Ther (2015)

PLCε knockdown prevents serine/glycine metabolism and proliferation of prostate cancer by suppressing YAP

Por Duan, Li-Mei, Liu, Jia-Yu, Yu, Chao-Wen, Fan, Jia-Xin, Li, Ting, Yang, Jin-Xiao, Zheng, Yong-Bo, Liu, Feng-Chun, He, Zhen-Ting, Yuan, Hong-Ling, Wu, Xiao-Hou, Luo, Chun-Li
Publicado no Am J Cancer Res (2020)